Latest Breaking News On - முக்கியமான மைல்கல் - Page 8 : comparemela.com

rBIO Achieves Crucial Milestone on Mission to Lower the Cost of Insulin by 30% Biotech startup has developed a new genetic coding process to synthesize proteins and peptide hormones; rBIO s platform for synthetic insulin achieves success as the team looks to production scale-up and a range of other prescription drugs to target News provided by Share this article Share this article SAN FRANCISCO, Dec. 17, 2020 /PRNewswire/  rBIO, an early-stage synthetic biology company focused on reducing the cost of prescription drugs, has announced its first in-lab milestone: synthetic production of human insulin. With its genetic coding platform and process now proven, the company is now poised to upscale production of insulin and to identify other prescription drugs that can be manufactured using rBIO s method for synthetically coding microorganisms.

Crucial milestoneமுக்கியமான மைல்கல்